BetterLife Pharma Inc. (OTCMKTS:BETRF) Short Interest Up 22,100.0% in October

BetterLife Pharma Inc. (OTCMKTS:BETRF) was the target of a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 22,200 shares, an increase of 22,100.0% from the October 15th total of 100 shares. Based on an average trading volume of 77,700 shares, the short-interest ratio is currently 0.3 days.

BetterLife Pharma Trading Up 8.5 %

Shares of BETRF traded up $0.01 during mid-day trading on Tuesday, reaching $0.08. The company had a trading volume of 6,650 shares, compared to its average volume of 29,799. The stock has a market cap of $10.36 million, a price-to-earnings ratio of -2.67 and a beta of 1.27. The firm has a fifty day simple moving average of $0.09 and a 200-day simple moving average of $0.09. BetterLife Pharma has a fifty-two week low of $0.03 and a fifty-two week high of $0.15.

BetterLife Pharma (OTCMKTS:BETRF) last posted its quarterly earnings results on Wednesday, September 25th. The company reported ($0.01) EPS for the quarter.

BetterLife Pharma Company Profile

BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.